【臨時】緑内障患者が待ち望んだロープレッサ（ネタルスジル）がついに承認！（遺伝子検査・網膜色素変性について）

This was introduced about a year ago. "About Netaludil"    • 【速報】緑内障治療の革新的新薬ネタルスジル！日本での承認申請が始まる   "Explanation of how it will change in a live broadcast" https://youtube.com/live/jWg0qkrNvy0 Related new drug: Cetaneo    • 10日で眼圧が11mmHgに？新しい緑内障治療の衝撃~セタネオ～      • 【臨時】２０２５年話題の新しい緑内障治療薬「セタネオ：セぺタプロスト」とは？   Free email newsletter where you can also see "exclusive information" you won't miss: https://i-magazine.bme .jp/bm/p/f/tf.php?id=jdx01500&task=regist Become a member of this channel to access perks:    / @hiramatsurui   [Must-See] Things You Should Know If You Seriously Want to Do Something About Glaucoma - A Must-See at Least Once in Your Life    • 【必見】一生に一度は見ておくべき、緑内障本気でどうにかしたいなら知っておくべき事   The glaucoma playlist contains various glaucoma information.    • 緑内障   ★Book What Doctors' Families Know! The Ultimate Truth About Glaucoma That Will Change Your Life https://amzn.to/3OzEL71 【Timestamps】 00:00 - Start 00:06 - How the new glaucoma drug "Lopressa" offers hope to patients 00:26 - Announcement of manufacturing and marketing approval for the new glaucoma drug "Lopressa (Netaludil)" 01:01 - The advantage of Lopressa's major feature: "once-daily eye drops" 01:56 - Explanation of Lopressa's mechanism of action: "Lock inhibitor" 02:48 - Explanation of the basic classification of glaucoma eye drops by action (water-water-leaching inhibition and water-water-leaching promotion) 04:38 - Explanation of Lopressa's additional action not found in the existing drug Granatec (norepnephrine transporter inhibition) 05:06 - Summary of how Lopressa lowers intraocular pressure through "double and triple" actions. 06:30 - Results of the "Mercury 1" trial, which showed a more than 30% reduction in intraocular pressure when used in combination with other eye drops. 06:52 - Main side effects of Lopressor (severe edema) and expected reduction in intraocular pressure (4-5 mmHg). 07:34 - Approval status of Lopressor overseas and the delay in approval in Japan. 09:02 - Specific anticipated use cases of Lopressor (additional medication, option before considering surgery). 11:13 - The role of Lopressor in situations requiring surgery and important warnings. 12:17 - The message of "Don't give up" in glaucoma treatment. 13:16 - Viewer question: Expiration date and storage method of glaucoma eye drops. 14:45 - Reasons why a one-month expiration date for eye drops is recommended (decrease in effectiveness). 17:11 - Viewer question: Genetic testing for retinitis pigmentosa. 18:40 - The role and limitations of genetic testing in the diagnosis of retinitis pigmentosa. 19:52 - Ethical and social reasons why indiscriminate genetic testing is not recommended. The new glaucoma drug, Lopressa, has received manufacturing and marketing approval. It's great news that a new drug will soon be available.    • 【臨時】緑内障患者が待ち望んだロープレッサ（ネタルスジル）がついに承認！（遺伝子検査...   A new glaucoma drug was approved on June 19, 2026. This video provides a detailed explanation of the effects and characteristics of this new glaucoma treatment drug, which only requires once-daily administration. A new treatment option has emerged for glaucoma, which causes vision loss. This video explains the benefits of this new drug for those currently using Granatec or those who find the frequency of eye drops burdensome. We have also compiled data on overseas performance and potential side effects, so please use this as a reference when consulting with your doctor. This explanation clearly outlines the specific characteristics of this new drug and how it differs from conventional treatments. In particular, we delved into how the convenience of once-daily medication impacts patients' lives, especially in glaucoma treatment, which requires daily administration. If you are considering a new treatment option, please be sure to check out the content. We will continue to provide the latest information on glaucoma treatment. Please let us know in the comments section if you have any questions about medications or topics you would like us to cover in the future.